Filing Details

Accession Number:
0001209191-21-021320
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-17 16:17:19
Reporting Period:
2021-03-15
Accepted Time:
2021-03-17 16:17:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1785406 Kathleen Ford C/O Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego CA 92130
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-15 6,250 $19.43 6,250 No 4 M Direct
Common Stock Disposition 2021-03-15 6,250 $29.43 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Disposition 2021-03-15 6,250 $0.00 6,250 $19.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
215,625 2029-08-08 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $29.43 to $29.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This option vests in 48 equal monthly installments commencing on August 9, 2019.